Excel-Pharma Revenue and Competitors

Location

N/A

Total Funding

HR

Industry

Estimated Revenue & Valuation

  • Excel-Pharma's estimated annual revenue is currently $6.1M per year.(i)
  • Excel-Pharma's estimated revenue per employee is $160,800

Employee Data

  • Excel-Pharma has 38 Employees.(i)
  • Excel-Pharma grew their employee count by -22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M11N/AN/AN/A
#2
$40.2M182-1%N/AN/A
#3
$0.6M6N/AN/AN/A
#4
$25.1M125N/AN/AN/A
#5
$1.3M1138%N/AN/A
#6
$6.9M43-28%N/AN/A
#7
$41.8M189N/AN/AN/A
#8
$0.8M8-33%N/AN/A
#9
$9.9M5545%N/AN/A
#10
$78.4M3125%N/AN/A
Add Company

Excel-Pharma grew from an idea that was as simple as it was ambitious: set the standard for pharmacist and PTA replacement services. We did this by putting together a solid team that excels in every aspect of the business. Our replacement pharmacists and PTA are selected with the utmost care and attention to detail. By being proactive, available and attentive, were able to provide truly world-class client service. And were always on the lookout for new talent so that our The Shedule app maximizes effectiveness through actual live matching.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$6.1M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Excel-Pharma News

2022-04-19 - LEIGE BASTOGNE LEIGE PREVIEW - THE MEN

... Madouas and Romain Bardet who lengthen the list of French riders who are in a position to excel. ... Equipo Kern Pharma: Adria (Spa).

2022-04-17 - Equity Research Associate Healthcare, Specialty Pharma

The team may also consider candidates from Investment Banking and/or Capital Markets. • Experience utilizing Excel to Build / Maintain Financial models, an...

2022-04-17 - Global CAR-T Cell Therapies: 2022 Intellectual Property ...

... namely a MS Excel sheet, featuring an interactive dashboard, ... MEDICINE HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M3823%N/A
#2
$6.9M38-3%N/A
#3
$4.4M38N/AN/A
#4
$6.6M39N/AN/A
#5
$7.8M40-2%N/A